Clinical Trial Update: O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II trial evaluating the combination of O6-benzylguanine and carmustine in patients with multiple myeloma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Carmustine (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED